Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.
about
Histological and molecular evaluation of patient-derived colorectal cancer explantsPatient-derived tumour xenografts as models for oncology drug developmentPatient-derived tumor xenografts: transforming clinical samples into mouse modelsMechanisms of drug resistance in colon cancer and its therapeutic strategiesPatient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewOne mouse, one patient paradigm: New avatars of personalized cancer therapyAppropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancersUsing heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerDevelopment and characterization of xenograft model systems for adenoid cystic carcinoma.Discovery and preclinical validation of drug indications using compendia of public gene expression data.Novel translational strategies in colorectal cancer research.The promise of patient-derived xenografts: the best laid plans of mice and menCellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.Pre-clinical mouse models of human prostate cancer and their utility in drug discoveryRegorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancer.Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient miceEstablishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumorsMolecular markers that predict response to colon cancer therapy.Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.Polymorphism of genes and implantation failure.Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies.Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.Implications of intratumour heterogeneity for treatment stratification.Apoptosis and molecular targeting therapy in cancer.Modeling of Patient-Derived Xenografts in Colorectal Cancer.Patient-derived xenografts as tools in pharmaceutical development.In vivo and in vitro activity and mechanism of action of the multidrug cytarabine-L-glycerylyl-fluorodeoxyuridine.Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.Bi-PROF: bisulfite profiling of target regions using 454 GS FLX Titanium technologyPrimary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment.Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.
P2860
Q21134541-B58E08E0-DB2B-44A0-8E4A-7CEE5ADCFB12Q24604068-B45791A0-C68E-404E-9EA0-0DDF56C88CA8Q24627425-E7C8BA40-F071-4553-8245-96B9630AB0A6Q26738528-28D5DE44-22DD-42A2-9B79-813A59A3A24AQ26741651-C89466AA-6CB4-4454-8437-816C34141397Q27023342-E9586DF0-3435-4265-8F1C-6B96AC01676EQ28545204-1A85047A-6998-4F36-94C6-F672EFD8FC30Q30409503-616196D1-0A7C-478C-9B48-596CA1B256A9Q30410903-DCF10FF3-AD2A-4548-A6C9-38C0741F3899Q33995422-A46AF09C-1612-4FFC-808C-C3D161D2938AQ34382804-82505D71-6AAD-44CF-8DA8-70D1A2D9CC53Q34443008-3DA47006-3C97-4CAB-90A2-7954C43BE425Q34567805-047BD064-023F-4D5B-A063-7CAA55EACC85Q34771567-3E0F4270-E357-44D1-A904-005ED712FA3DQ34776150-FD17AD09-0ADF-4685-B970-2FD6F1731DE6Q34792522-91B5C1E0-97C2-4044-99C6-EDD8586E077AQ35053317-E8EB2549-807C-4ED3-B7A4-7884CF2D910AQ35119526-CCE79BFE-1B0E-4436-9AE9-4B9163466CF6Q35832158-6416A1B3-134D-453E-8055-49CA3D1D2658Q36150356-D0363781-B82A-4599-BA0E-4ADAF6B5E030Q36242926-00B2F058-A388-47F0-A55C-3B33EC4AA5C1Q36633405-EB3A99AA-96CF-43CD-B1EC-F07349B539D9Q37324241-86BDDD0D-5EB9-4DEC-8D5E-AA47E90E266FQ37387342-E5E4511C-4DC1-4F85-9629-AB5BAD0B8941Q37576633-8C86EBB9-575D-48F1-BD61-C16FD8CED391Q37635313-CE2A6AC9-52DB-4442-BE2B-CD990D75F047Q37642614-73E601AE-7D0F-4B4C-9435-5415E1422D1AQ38151633-3B7F8AB9-1AEB-4CF2-84AB-37AC7664D6E3Q38228349-6305D51D-5BC9-4F37-9E79-97F6364F0024Q38705019-165FE5C7-6860-45B3-A794-1A093CB0EA4FQ38732336-444F1CC4-6C71-4F8F-81AE-8C48188B87F1Q40037925-61E590A5-32E9-4BA6-99CF-11A3812C35E2Q40129598-F9708F44-A786-4FE9-AB23-81B6A2F1DC0BQ40416521-6FEE049A-97A6-4026-94FD-0F30CDE5E0C9Q41069109-75A79536-54CA-4306-8F18-DEF84B521378Q41339763-E6925A79-D5E2-4A87-A39D-C7104FD8FF1CQ41830742-A26F0F69-6676-4A61-9AB3-26A00A65AE04Q41977375-EFA6FC24-2A8C-4447-B992-BCF8A1341D7CQ44944972-F4A1BFFD-098B-4D2B-90D4-930614EAE38FQ45068320-F9A0E11B-BC78-4490-B0ED-84F0295DABA2
P2860
Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Anticancer drug response and e ...... transplanted colon carcinomas.
@en
Anticancer drug response and e ...... transplanted colon carcinomas.
@nl
type
label
Anticancer drug response and e ...... transplanted colon carcinomas.
@en
Anticancer drug response and e ...... transplanted colon carcinomas.
@nl
prefLabel
Anticancer drug response and e ...... transplanted colon carcinomas.
@en
Anticancer drug response and e ...... transplanted colon carcinomas.
@nl
P2093
P1476
Anticancer drug response and e ...... otransplanted colon carcinomas
@en
P2093
P304
P356
10.1016/J.EJCA.2003.10.011
P577
2004-01-01T00:00:00Z